Valuation: AstraZeneca PLC

Market Cap 267B 235B 219B 201B 376B 25,575B 386B 2,597B 1,016B 12,656B 1,002B 981B 43,751B P/E 2026 *
22x
P/E 2027 * 19.2x
Enterprise Value 287B 252B 235B 216B 404B 27,496B 414B 2,792B 1,092B 13,606B 1,078B 1,054B 47,037B EV / Sales 2026 *
4.54x
EV / Sales 2027 * 4.18x
Free-Float
96.63%
Yield 2026 *
1.93%
Yield 2027 * 2.05%
1 day+1.34%
1 week+3.40%
Current month-6.85%
1 month-8.14%
3 months-4.08%
6 months-2.42%
Current year-4.76%
1 week 12,444.86
Extreme 12444.858
13,164
1 month 10,524
Extreme 10524
14,686
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Free

See Remarks

2 0.0000%
6/8/26 Free

See Remarks

1 0.0000%
5/20/26 Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%+3.40%+17.71%+17.41% 267B
-0.34%+4.73%+59.64%+167.96% 1,089B
-0.47%+4.41%+58.77%+59.31% 643B
+1.01%+5.09%+39.21%+77.96% 465B
-1.69%+8.81%+39.38%+33.67% 359B
-0.51%+3.51%+36.97%+42.46% 303B
+0.79%+5.81%-2.55%-38.10% 226B
-0.97%+6.55%+28.49%+66.57% 212B
-0.32%+2.95%+17.46%+76.23% 167B
-0.42%+1.52%+3.70%-30.12% 144B
Average -0.17%+4.53%+29.88%+47.34% 387.5B
Weighted average by Cap. -0.23%+4.94%+41.27%+77.61%

Financials

2026 *2027 *
Net sales 63.29B 55.61B 51.91B 47.64B 89.18B 6,062B 91.38B 616B 241B 3,000B 238B 232B 10,370B 66.84B 58.73B 54.82B 50.31B 94.18B 6,402B 96.5B 650B 254B 3,168B 251B 245B 10,952B
Net income 12.08B 10.62B 9.91B 9.1B 17.03B 1,158B 17.45B 118B 45.97B 573B 45.37B 44.39B 1,980B 13.71B 12.05B 11.25B 10.32B 19.32B 1,313B 19.79B 133B 52.15B 650B 51.47B 50.36B 2,246B
Net Debt 20.05B 17.62B 16.45B 15.1B 28.26B 1,921B 28.95B 195B 76.28B 951B 75.29B 73.66B 3,286B 12.56B 11.04B 10.3B 9.46B 17.7B 1,203B 18.14B 122B 47.78B 595B 47.17B 46.14B 2,058B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-29 GBX 13,134.00 +1.50% 2,910,486
26-07-28 GBX 12,940.00 +0.40% 2,837,787
26-07-27 GBX 12,888.00 +1.72% 2,548,927
26-07-24 GBX 12,670.00 -0.14% 1,845,837
26-07-23 GBX 12,688.00 -0.11% 4,046,281
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
172.15USD
Average target price
212.36USD
Spread / Average Target
+23.35%

Quarterly revenue - Rate of surprise